0

531521

DESHRAK

img img img img
No Data Available

DESH RAKSHAK AUSHDHALAYA LTD. Share Price Update

As of the latest trading session, DESH RAKSHAK AUSHDHALAYA LTD. is trading at ₹23.62, up by ₹0.00 or 0.00% from its previous close. The stock has moved between ₹23.62 and ₹23.62 today. Over the past year, the stock has delivered a return of -27.98%. In the last month, it has returned -12.51%.

Investment Returns

Over 1 Month -12.51% Over 3 Months -24.53% Over 6 Months -46.08% Over 1 Year -27.98%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

DESH RAKSHAK AUSHDHALAYA LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 13.50
  • P/E Ratio (TTM) 21.47
  • Beta 0.61
  • Book Value / share 22.14
  • Return on equity 4.97%
  • EPS (TTM) 1.10
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.09
info icon alternate text

DESH RAKSHAK AUSHDHALAYA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars DEC 2025 (Values in Cr)
Revenue 1.40
Operating Expense 1.31
Net Profit 0.09
Net Profit Margin (%) 6.42
Earnings Per Share (EPS) 0.16
EBITDA 0.25
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.95
Operating Expense 0.87
Net Profit 0.08
Net Profit Margin (%) 8.42
Earnings Per Share (EPS) 0.15
EBITDA 0.26
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 1.30
Operating Expense 1.20
Net Profit 0.10
Net Profit Margin (%) 7.69
Earnings Per Share (EPS) 0.22
EBITDA 0.25
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 4.39
Operating Expense 3.96
Net Profit 0.36
Net Profit Margin (%) 8.20
Earnings Per Share (EPS) 0.80
EBITDA 0.97
Effective Tax Rate (%) 20.45
Particulars DEC 2024 (Values in Cr)
Revenue 1.88
Operating Expense 1.78
Net Profit 0.12
Net Profit Margin (%) 6.38
Earnings Per Share (EPS) 0.27
EBITDA 0.31
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 6.27
Operating Expense 5.74
Net Profit 0.48
Net Profit Margin (%) 7.65
Earnings Per Share (EPS) 1.07
EBITDA 1.28
Effective Tax Rate (%) 16.07
Particulars MAR 2024 (Values in Cr)
Revenue 6.01
Operating Expense 5.53
Net Profit 0.43
Net Profit Margin (%) 7.15
Earnings Per Share (EPS) 0.96
EBITDA 1.31
Effective Tax Rate (%) 15.68
Particulars MAR 2023 (Values in Cr)
Revenue 6.18
Operating Expense 5.70
Net Profit 0.41
Net Profit Margin (%) 6.63
Earnings Per Share (EPS) 0.91
EBITDA 1.32
Effective Tax Rate (%) 16.66
Particulars MAR 2022 (Values in Cr)
Revenue 6.19
Operating Expense 5.63
Net Profit 0.48
Net Profit Margin (%) 7.75
Earnings Per Share (EPS) 1.08
EBITDA 1.20
Effective Tax Rate (%) 15.78
Particulars MAR 2021 (Values in Cr)
Revenue 6.60
Operating Expense 6.07
Net Profit 0.42
Net Profit Margin (%) 6.36
Earnings Per Share (EPS) 0.95
EBITDA 0.96
Effective Tax Rate (%) 23.63
Particulars MAR 2025 (Values in Cr)
Book Value / Share 21.23
ROE % 4.97
ROCE % 6.98
Total Debt to Total Equity 0.30
EBITDA Margin 20.57
Particulars MAR 2024 (Values in Cr)
Book Value / Share 20.21
ROE % 4.65
ROCE % 6.90
Total Debt to Total Equity 0.37
EBITDA Margin 21.80
Particulars MAR 2023 (Values in Cr)
Book Value / Share 19.46
ROE % 5.03
ROCE % 7.09
Total Debt to Total Equity 0.46
EBITDA Margin 22.49
Particulars MAR 2022 (Values in Cr)
Book Value / Share 19.78
ROE % 5.35
ROCE % 6.41
Total Debt to Total Equity 0.40
EBITDA Margin 19.55
Particulars MAR 2021 (Values in Cr)
Book Value / Share 18.75
ROE % 4.91
ROCE % 6.37
Total Debt to Total Equity 0.29
EBITDA Margin 14.70
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.06
Total Assets 17.97
Total Liabilities 17.97
Total Equity 9.95
Share Outstanding 0
Price to Book Ratio 1.42
Return on Assets (%) 2.65
Return on Capital (%) 3.67
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 16.32
Total Liabilities 16.32
Total Equity 9.47
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 2.61
Return on Capital (%) 3.49
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 15.73
Total Liabilities 15.73
Total Equity 9.13
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 2.57
Return on Capital (%) 3.06
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 16.12
Total Liabilities 16.12
Total Equity 9.28
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 2.98
Return on Capital (%) 3.54
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.59
Total Assets 14.57
Total Liabilities 14.57
Total Equity 8.80
Share Outstanding 0
Price to Book Ratio 0.22
Return on Assets (%) 2.88
Return on Capital (%) 3.59
Particulars MAR 2025 (Values in Cr)
Net Income 0.56
Cash from Operations -0.20
Cash from Investing -0.01
Cash from Financing 0.24
Net change in Cash -0.06
Free Cash Flow 0.36
Particulars MAR 2024 (Values in Cr)
Net Income 0.50
Cash from Operations 1.68
Cash from Investing -0.08
Cash from Financing -1.34
Net change in Cash 0.08
Free Cash Flow 1.73
Particulars MAR 2023 (Values in Cr)
Net Income 0.48
Cash from Operations 0.49
Cash from Investing -0.77
Cash from Financing 0.14
Net change in Cash -0.17
Free Cash Flow 1.30
Particulars MAR 2022 (Values in Cr)
Net Income 0.57
Cash from Operations 0.32
Cash from Investing -1.94
Cash from Financing 1.34
Net change in Cash -0.36
Free Cash Flow 2.06
Particulars MAR 2021 (Values in Cr)
Net Income 0.54
Cash from Operations 0.96
Cash from Investing -1.26
Cash from Financing 0.79
Net change in Cash 0.37
Free Cash Flow 2.34
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.41 14.03 1.68 248.37 23.12 40.44
BLISS GVS PHARMA LTD 274.40 26.23 2.56 2902.85 105.05 280.20
CIPLA LTD 1334.85 22.68 3.27 107826.86 1165.55 1672.20
FERMENTA BIOTECH LIMITED 299.35 9.96 2.25 881.02 252.15 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2351.10 39.60 23.32 39829.05 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.41 31.16 4.51 248.37 23.12 40.44
AMRUTANJAN HEALTH CARE LTD. 577.00 28.85 4.87 1668.14 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8046.55 96.70 25.17 20116.38 7630.00 10653.05
BLISS GVS PHARMA LTD 274.40 37.38 2.63 2902.85 105.05 280.20

DESH RAKSHAK AUSHDHALAYA LTD. shareholding pattern

Holding
49.97%
50.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

DESH RAKSHAK AUSHDHALAYA LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
23.62 4.97 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 24.00
  • 26 Days 27.70
  • 10 Days 24.80
  • 50 Days 32.80
  • 12 Days 25.10
  • 100 Days 36.60
  • 20 Days 26.50
  • 200 Days 31.90
23.62 PIVOT
First Support 23.62 First Resistance 23.62 Second Support 23.62 Second Resistance 23.62 Third Support 23.62 Third Resistance 23.62
RSI 33.22 ADX 49.49 MACD -2.61 Williams % R -79.75 Commodity Channel Index (CCI) -87.67
Date 2026-04-30 Week 367.00 Same Day 100.00 Month 933.00
1 Year 0.61 3 Year 0.56
Over 1 Month
-12.51% down
Over 1 Year
-27.98% down
Over 3 Months
-24.53% down
Over 3 Years
60.33% down
Over 6 Months
-46.08% down
Over 5 Years
43.29% down

DESH RAKSHAK AUSHDHALAYA LTD. Corporate Actions

Top Gainers

Top Losers

DESH RAKSHAK AUSHDHALAYA LTD. Share Price

The flagship company Desh Rakshak Aushdhalaya Limited of Bhagwant Group was originally started in 1901 as a Proprietorship Concern by Late Shri Bhagwant Rai Jain, a well renowned Vaidya Father of Late Dr. Paras Kumar Jain. The Concern was converted into a Private Limited Company in Jul.'94.

Desh Rakshakare the oldest manufacturer of Pure Ayurvedic and Herbal Products as discovered by the Ancient Seers & Sages. The medicines are categorized into Proprietary & Classical Medicines. They are currently manufacturing around 450 products (Proprietary & Classical mix) and all of these medicines are manufactured as per the prescribed norms and standards of the Indian Government. The Company was earlier operating the traditional process of manufacturing ayurvedic medicines.

Up to 1976, the company producing ethical products of ayurvedic medicines which were supplied to ayurvedic dispensaries. In 1977, the Government of India (GoI) had announced certain policies like Community Health Volunteer Scheme, for the benefits of the rural public. The company participated in the bulk supply under the scheme. In 1986-87, due to the change in the government policy, it again started the production of ethical and patent ayurvedic medicines.

In 1995-96, the company undertook a modernisation programme to upgrade the quality of its products and launch them in the global market and also an expansion programme to increase the installed capacity of tablets to 2050 lac pa; liquid to 41 lac bottles pa; pills to 27.50 lac pa; awleha to 280 tons per annum (tpa); kwath to 40 tpa and capasules to 60 lac pa. The project was part financed through a public issue in Dec.'95.

The Company has a wide range of ethical healthcare products based upon the age-old system of Ayurveda. It has ethical medicines that are derived from herbs and form part of this holistic healthcare system, focusing on all-round well-being. The range was promoted aggressively through focused activities.

Parent organization Indian Private
NSE symbol [-]
Founded 1981
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Desh Rakshak Aushdhalaya Ltd?

Answer Field

Desh Rakshak Aushdhalaya Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 23.62 as on Apr 30 2026 12:00 AM.

What is the Market Cap of Desh Rakshak Aushdhalaya Ltd Share?

Answer Field

The market cap of Desh Rakshak Aushdhalaya Ltd for NSE ₹ 0.00 & for BSE ₹ 13.50 as on Apr 30 2026 12:00 AM.

What is the 52 Week High and Low of Desh Rakshak Aushdhalaya Ltd?

Answer Field

The 52 Week High and Low of Desh Rakshak Aushdhalaya Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 95.14 and ₹ 22.50.

What is 1 year return for Desh Rakshak Aushdhalaya Ltd?

Answer Field

The 1 year returns on the stock has been -27.98%.

What is the P/E Ratio of Desh Rakshak Aushdhalaya Ltd Share?

Answer Field

As on Apr 30 2026 12:00 AM the price-to-earnings (PE) ratio for Desh Rakshak Aushdhalaya Ltd share is 21.47.

What is the PB ratio of Desh Rakshak Aushdhalaya Ltd Share?

Answer Field

As on Apr 30 2026 12:00 AM, the price-to-book (PB) ratio for Desh Rakshak Aushdhalaya Ltd share is 22.14.

How to Buy Desh Rakshak Aushdhalaya Ltd Share?

Answer Field

You can trade in Desh Rakshak Aushdhalaya Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Desh Rakshak Aushdhalaya Ltd Share on Bajaj Broking App?

Answer Field

To buy Desh Rakshak Aushdhalaya Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Desh Rakshak Aushdhalaya Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|